CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study

BACKGROUND: Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) has been described as a biomarker for microglial activation, which were observed increased in a variety of neurological disorders. OBJECTIVE: Our objective was to explore whether genetically de...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Ming-Hao, Zhou, Luo-Qi, Tang, Yue, Chen, Man, Xiao, Jun, Shang, Ke, Deng, Gang, Qin, Chuan, Tian, Dai-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985278/
https://www.ncbi.nlm.nih.gov/pubmed/35382840
http://dx.doi.org/10.1186/s12974-022-02443-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985278/
https://www.ncbi.nlm.nih.gov/pubmed/35382840
http://dx.doi.org/10.1186/s12974-022-02443-9

Ejemplares similares